F
amily history of diabetes appears to increase the risk of coronary heart disease (CHD), even in nondiabetic subjects (1) . Differences in anthropometric, metabolic, cardiovascular, and hemostatic parameters may explain this phenomenon. When compared with individuals with no family history of diabetes, nondiabetic first-degree relatives of type 2 diabetic patients (individuals with a family history of diabetes) were found to have increased abdominal fat content (2) and more elevated systolic blood pressure levels (3) and higher plasma concentrations of triglyceride and cholesterol (3), plasminogen activator inhibitor-1 activity (4), and ceruloplasmin plasma levels (5) . They also showed decreased HDL plasma levels (2, 3) , sensitivity to activated protein C (5), endothelial-dependent vasodilation (6) , and aortic distensibility (7) . These findings strongly support the existence of a link between genetic predisposition to type 2 diabetes and increased risk of atherothrombosis.
The increased intima-media thickness of the common carotid artery (IMT-CCA), as measured by high-resolution B-mode ultrasound imaging, is a very early phase of the atherosclerotic process and precedes the development of plaque and stenosis in the arterial wall (8, 9) . IMT-CCA was found to be associated with a higher prevalence of symptomatic and asymptomatic CHD and to correlate with future development of myocardial infarction and stroke (10) , thus suggesting that thickening of the IMT-CCA may represent a surrogate marker of coronary atherosclerosis.
Whether a family history of type 2 diabetes may influence the carotid wall has not been investigated. Therefore, we studied young adults with normal glucose tolerance (NGT) with or without family history of type 2 diabetes and with various degrees of adiposity 1) to test whether family history of diabetes (defined as having one or both parents with type 2 diabetes) is associated with increased IMT-CCA and 2) to evaluate the relationship of IMT-CCA with anthropometric and metabolic parameters. (11) .
RESEARCH DESIGN AND METHODS
Overweight and obese patients were recruited consecutively at the Outpatient Clinic of the Section on Internal Medicine, Endocrinology, and Metabolic Diseases, Department of Emergency and Organ Transplantation, University of Bari School of Medicine (Bari, Italy). Normalweight subjects were healthy volunteers; those with family history of type 2 diabetes were recruited among offspring of patients with type 2 diabetes attending the Outpatient Clinic for the Study of Diabetes at the same institution, whereas those with no family history of type 2 diabetes were recruited among physicians and medical students. All parents of subjects enrolled in the study were alive at the beginning of the study. All individuals gave written informed consent to be included in the study, which was performed in accordance with the guidelines proposed in the Declaration of Helsinki.
To avoid confounding factors known to affect endothelial function, coagulation pathways, and/or glucose metabolism, the following subjects were not included in the study: smokers during the previous 12 months, subjects with diagnosed cardiovascular disease (coronary artery disease, arrhythmia, and heart failure), subjects with cerebrovascular disease (stroke and transient ischemic attack), subjects with peripheral vascular disease (claudicatio intermittens and/or absence of peripheral pulses), subjects with familial and/or severe dyslipidemia (triglycerides and/or total cholesterol Ͼ300 mg/ dl), subjects with stable hypertension treated by drugs, and subjects with chronic hepatic, renal, or any other serious chronic disease. Subjects were also excluded if they were taking any kind of medications, including oral contraceptives. Finally, during the testing period, all subjects were asked to maintain their normal mixed diet and not to perform any sports activities. Subjects were evaluated after an overnight fast and a 24-h period of abstinence from alcohol and vigorous physical exercise. A standard 75-g oral glucose tolerance test was performed in each subject enrolled in the study for evaluating glucose status and basal, 1-h postchallange, and 2-h postchallenge glucose concentrations. The systolic and diastolic blood pressure readings were recorded to the nearest 2 mmHg as the mean of two measurements with the subjects seated using a mercury sphygmomanometer with an appropriate cuff size. Central fat accumulation was evaluated by measuring the waist circumference, defined as the minimum circumference between the xiphoid process and the umbilicus.
Blood samples were drawn from an antecubital vein with a 19-gauge needle. Plasma concentrations of insulin were measured by radioimmunological assay using a commercially available kit (Behring, Scoppitto, Italy). Blood glucose levels were determined by the glucoseoxidase method (Sclavo, Siena, Italy). Total cholesterol, HDL cholesterol, and triglyceride levels were measured using enzymatic assays (Boehringer Mannheim, Diagnostica Mannheim, Mannheim, Germany). LDL cholesterol content was calculated by the Friedewald equation (LDL cholesterol ϭ total cholesterol -[HDL cholesterol ϩ triglycerides/5]). Insulin resistance was assessed by using the homeostasis model assessment (HOMA), based on a mathematical correlation between fasting plasma glucose and insulin levels (12) .
Measurements of IMT-CCA were obtained from the far wall of the distal common carotid arteries (immediately proximal to the carotid bulb) and reported as the mean value for the bilateral measurement. This location was chosen a priori because of its demonstrated reproducibility, compared with measurements of IMT-CCA at other sites (13) . All studies were performed on a single ultrasound machine (Hewlett-Packard Sonos 1000B) 
Pannacciulli and Associates
DIABETES CARE, VOLUME 26, NUMBER 4, APRIL 2003using a linear-array 8-MHz scan head with standardized image settings, including resolution mode, depth of field, gain, and transmit focus. Ultrasound study was performed in a standard fashion by an examiner who was specifically trained to perform the prescribed study examination. All sonograms were obtained with the patient in the supine position and the head turned slightly to the contralateral side. Each ultrasound examination was performed as an independent study, without any knowledge of the family history of type 2 diabetes. The near-field (intimal-luminal surface) and far-field (medial-adventitial) arterial wall borders were manually traced for measurement of minimal and maximal IMT-CCA. The precision and reliability of the ultrasound method was tested in a randomly selected subgroup of 21 arteries with paired images obtained on the same day. The mean difference in IMT-CCA between these images was 0.016 mm, and the intraclass correlation coefficient was 0.91 (P Ͻ 0.001). Paired IMT measurements in the same arteries showed a high degree of reproducibility; the mean difference in IMT was 0.021 mm, and the intraclass correlation coefficient was 0.96 (P Ͻ 0.001). Statistical analyses were performed using the STATISTICA 6.0 for Windows software (StatSoft, Tulsa, OK). Results are presented as average and SEM for all parameters. The K-S test and the Lilliefors test for normality were performed to determine whether the wide range of BMI in each group, including normal weight, overweight, and obese subjects, could be a sign of bimodal distribution. Because both tests were not significant (P Ͼ 0.2), it could be argued that the three subgroups, i.e., normal weight, overweight, and obese, could be tested as a whole (data not shown). Student's t test for independent samples was used to evaluate the differences between FH ϩ and FH Ϫ individuals and between subjects with maternally and paternally inherited type 2 diabetes. The differences among subjects with no family history of type 2 diabetes, subjects with only one parent with type 2 diabetes, and subjects with both parents affected by type 2 diabetes were evaluated by oneway ANOVA. Pearson's correlation coefficients were used to quantify the univariate associations among variables, and a multiple regression analysis was performed to test the joint effect of different variables on IMT-CCA as the dependent variable. Variables with a skewed distribution (plasma levels of triglycerides and insulin) were logarithmically transformed before analysis to improve the approximation to a Gaussian distribution. The minimal statistical significance was defined for P Ͻ 0.05.
RESULTS -General, anthropometric, biochemical, and ultrasonographic data of FH ϩ and FH Ϫ individuals are presented in Table 1 . IMT-CCA and both 1-and 2-h postchallenge glucose concentrations were significantly higher in FH ϩ than in FH Ϫ subjects (P Ͻ 0.001, P Ͻ 0.01, and P Ͻ 0.01, respectively). The difference in IMT-CCA between FH ϩ and FH Ϫ individuals was maintained also in the subgroup of normal-weight subjects (data not shown). No significant difference between the two groups was found for any of the other variables investigated, including age and BMI. Similarly, we could not find any difference either in IMT-CCA or anthropometric and metabolic variables between subjects with maternal versus paternal family history of type 2 diabetes (data not shown). Figure 1 shows the results of the oneway ANOVA, performed to evaluate differences among subjects with no family history of diabetes (FH Ϫ , n ϭ 213), subjects with only one diabetic parent (FH 1ϩ , n ϭ 169), and subjects with both parents affected by type 2 diabetes (FH 2ϩ , n ϭ 19). Significant increases in IMT-CCA (F: 14.58, P Ͻ 0.001) and in basal (F: 3.54, P Ͻ 0.05), 1-h postchallenge (F: 5.99,
Figure 1-IMT-CCA (A), basal glucose (B), 1-h postchallenge glucose (C), 2-h postchallenge glucose (D), BMI (E), and waist circumference (F) in subjects with no family history of diabetes (Ⅺ), subjects with only one diabetic parent (o), and subjects with both parents affected by type 2 diabetes (f).
P Ͻ 0.01), and 2-h postchallenge glucose concentrations (F: 5.87, P Ͻ 0.01) were observed across the three subgroups. There was a tendency, even though not statistically significant (P ϭ 0.055 and 0.066, respectively), for both BMI and waist circumference values to increase across the subgroups. On the other hand, age (one of the most powerful predictors of IMT-CCA) was not different across the above subgroups (P ϭ 0.451).
The correlation coefficients between IMT-CCA and the other variables in all subjects (i.e., pooling FH ϩ and FH Ϫ subjects) are shown in Table 2 . IMT-CCA was positively correlated with age (P Ͻ 0.001), BMI (P Ͻ 0.001), waist circumference (P Ͻ 0.001), logarithmically transformed levels of triglycerides (P Ͻ 0.01), systolic and diastolic blood pressure levels (P Ͻ 0.01 and P Ͻ 0.001, respectively), basal, 1-h postchallenge, and 2-h postchallenge glucose concentrations (P Ͻ 0.001, P Ͻ 0.001, and P Ͻ 0.01, respectively), and HOMA for insulin resistance (HOMA IR ) (P Ͻ 0.05), and inversely associated with HDL cholesterol levels (P Ͻ 0.001). When IMT-CCA was considered as the dependent variable in a multiple regression analysis (fitted model: adjusted R 2 0.241, F: 13.114, P Ͻ 0.001) with sex (categorical variable), family history of type 2 diabetes (categorical variable), age, BMI or waist circumference, plasma lipids (total cholesterol, HDL cholesterol, or logarithmically transformed triglycerides), systolic or diastolic blood pressure, logarithmically transformed insulin levels, and basal, 1-h postchallenge, or 2-h postchallenge glucose concentrations as independent variables, IMT-CCA maintained an independent association with family history of type 2 diabetes (P Ͻ 0.01), BMI (P Ͻ 0.01), waist circumference (P Ͻ 0.01), HDL concentrations (P Ͻ 0.01), diastolic blood pressure (P Ͻ 0.05), and fasting glucose levels (P Ͻ 0.01). Similarly, when HOMA IR was entered into the regression model after excluding glucose and insulin levels (fitted model: adjusted R 2 0.203, F: 4.613, P Ͻ 0.0001), IMT-CCA maintained an independent association with family history of type 2 diabetes (P Ͻ 0.01), BMI (P Ͻ 0.01), waist circumference (P Ͻ 0.01), diastolic blood pressure (P Ͻ 0.05), and HDL concentrations (P Ͻ 0.01) but not with HOMA IR .
CONCLUSIONS -It is well established that the genetic predisposition to type 2 diabetes is associated with higher risk for CHD. We now show that normalweight, overweight, and obese glucosetolerant offspring of type 2 diabetic patients have higher IMT-CCA than ageand BMI-matched control subjects with no family history of type 2 diabetes. The role of the genetic predisposition to type 2 diabetes in influencing carotid atherosclerosis is strengthened by further observations. First, IMT-CCA was found to significantly increase across the three subgroups, in which the entire population was divided according to the absence of family history of type 2 diabetes, presence of type 2 diabetes in only one parent, or presence of type 2 diabetes in both parents. Second, IMT-CCA was still higher in FH ϩ than in FH Ϫ individuals when only normal-weight subjects were considered in the statistical analysis, suggesting that the effect of family history of type 2 diabetes on the arterial wall may be independent of obesity.
IMT-CCA has been shown to be associated with prevalence of cardiovascular disease and atherosclerotic involvement of other arterial beds, including the coronary arteries (8) , and to represent a strong predictor of both myocardial infarction and stroke (10, 14) , even in subjects with no history of cardiovascular disease (8) . Furthermore, ample evidence has been provided that the increase in cardiovascular risk begins well before the onset of overt diabetes and that, at this time, metabolic disturbances contribute to macrovascular rather than microvascular complications (15) . Therefore, the independent association between the genetic predisposition to type 2 diabetes and IMT-CCA in young healthy adults points to the fact that these subjects may be considered to be already affected by an early stage of atherosclerosis.
Because we found an independent association of IMT-CCA with fasting glucose concentrations and, furthermore, a gradual increase in basal, 1-h postchallenge, and 2-h postchallenge glucose concentrations according to the absence of family history of type 2 diabetes, presence of type 2 diabetes in only one parent, or presence of type 2 diabetes in both parents, respectively, we cannot rule out a harmful effect of slightly elevated glycemia on the vasculature, affecting endothelial function. Relevant to this concept, it should be noted that both fasting and postchallenge hyperglycemia are strong and independent risk factors for cardiovascular diseases also in nondiabetic subjects (16) . Recently, Balletshofer et al. (6) reported that endothelial dysfunction is detectable in young normotensive firstdegree relatives of subjects with type 2 diabetes. Because endothelial dysfunction represents an early disturbance in the development of atherosclerotic lesions (17) , one could hypothesize that slightly elevated fasting and/or postprandial glucose concentrations, as found in this study in offspring of type 2 diabetic patients, can cause a loss of endothelial function, leading to an increase in IMT-CCA. Noteworthy, no independent relationship was found between IMT-CCA and HOMA IR . This is not surprising, because the association of insulin resistance with carotid atherosclerosis could be explained by its cosegregation with established CHD risk factors, such as obesity, visceral fat, hypertension, and low HDL cholesterol levels. We found that IMT-CCA is positively associated with BMI, waist circumference, and diastolic blood pressure and negatively related to HDL cholesterol. Together, these findings support the concept that genetic predisposition to type 2 diabetes may contribute to development of atherosclerosis in susceptible individuals per se and/or through an array of subtle associated abnormalities in body fat, glucose and lipid metabolism, and blood pressure.
In conclusion, the present study demonstrates that the IMT-CCA is significantly higher in young adult normalweight, overweight, and obese glucosetolerant first-degree relatives of type 2 diabetic patients compared with control subjects with no family history of diabetes. Therefore, this study indicates that genetic predisposition to type 2 diabetes may accelerate development of atherosclerosis and, potentially, increase the risk of CHD.
